Cite
HARVARD Citation
Fayad, L. et al. (n.d.). Dacetuzumab plus rituximab, ifosfamide, carboplatin and etoposide as salvage therapy for patients with diffuse large B-cell lymphoma relapsing after rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone: a randomized, double-blind, placebo-controlled phase 2b trial. Leukemia & lymphoma. 56 (9), pp. 2569-2578. [Online].